-
www.innovations.ahrq.gov/pqmp/implementation-qi/toolkit/antipsychotic/references.html
July 01, 2021 - Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
January 01, 2011 - Tricyclic antidepressants should not be routinely used in treatment of
ADHD/HKD in children and should
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - Tricyclic antidepressants should not be routinely used in treatment of
ADHD/HKD in children and should
-
www.innovations.ahrq.gov/news/newsroom/ahrq-stats.html
November 01, 2023 - Skip to main content
An official website of the Department of Health and Human Services
Careers
Contact Us
Español
FAQs
Search all AHRQ sites
Search small
Search
Menu
…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - Adolescent Depression Remission/Response
1
Adolescent Depression Remission/Response
Section 1. Basic Measure Information
1.A. Measure Name
Adolescent Depression Remission/Response (Provider)
1.B. Measure Number
0247
1.C. Measure Description
Please provide a non-technical description of the measure that conv…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/teach-back-role-play-final508.pdf
April 05, 2018 - Teach-Back
Teach-Back
Teach-Back: Role Play Scenarios
The Guide to Improving Patient Safety in Primary Care
Settings by Engaging Patients and Families
Teach-Back
Role Play Scenario 1
Facilitator Instructions
1. As facilitator, play the role of the patient.
2. Request a volunteer to play the role of the clinici…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/fallprevention-training/module3/module3_tools.docx
January 01, 2012 - gait and balance, impaired cognition
2 (Medium)
Antihypertensives, cardiac drugs, antiarrhythmics, antidepressants … Check for medication associated with fall risk, such as antidepressants, sleeping tablets, sedatives,
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - Depression Remission or Response for Adolescents and Adults: Report
1
Depression Remission or Response for Adolescents
and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Depression Remission or Response for Adolescents and Adults
1.B. Measure Number
0244
1.C. Measure Description
Pleas…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0244-technical-specifications.pdf
March 01, 2016 - HEDIS Measures for 0244 Depression: Technical Specifications
Depression Screening and Follow-Up for Adolescents and Adults 1
Depression Screening and Follow-Up for Adolescents and Adults (DSF)*
*Adapted with financial support from CMS from a provider-level measure developed by
Quality Insights of Pennsylvania (QI…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/Lion-Mangione-Britto.pdf
October 01, 2011 - Adherence: Compared to controls, intervention patients had greater odds
of having used recommended antidepressants
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults: Report
Utilization of the PHQ-9 to Monitor Depression
Symptoms for Adolescents and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults
…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/fallsprev/ontimefallpxreports-ig.pdf
November 09, 2017 - balance)
History of fall in the last 180 days
Use of psychoactive medications (antipsychotics,
antidepressants … MDS assessment
documents the use of at least one of the following medications:
Antipsychotics
Antidepressants
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - Assessing the Availability of the Preconception Component of High-Risk Obstetrical Services by Estimating the Use of Teratogenic Medications Before and During Pregnancy
1
Assessing the Availability of the Preconception
Component of High-Risk Obstetrical Services by
Estimating the Use of Teratogenic Medications B…
-
www.innovations.ahrq.gov/patient-safety/reports/liability/neumiller.html
August 01, 2017 - Similar to our findings, the most common medication classes involved were antibiotics, antidepressants
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Depression Screening and Follow-up for Adolescents and Adults
1
Depression Screening and Follow-up for Adolescents
and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Depression Screening and Follow-up for Adolescents and Adults (Health Plan)
1.B. Measure Number
0246
1.C. Measure Description
P…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/LomotanDougherty2013.pdf
April 01, 2013 - Pediatric Health Care Quality Measures: Considerations for Pharmacotherapy
Pediatr Drugs
DOI 10.1007/s40272-013-0042-4
LEADING ARTICLE
Pediatric Health Care Quality Measures: Considerations
for Pharmacotherapy
Edwin A. Lomotan • Denise Dougherty
© Springer International Publishing Switzerland (outside th…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/meta/meta-analyses-refs.pdf
January 01, 2007 - Treating Tobacco Use and Dependence, 2008 Update: References for Studies in Meta-analyses
1
References for Studies Included in Meta-analyses
Table 6.4. Meta-analysis (1996): Impact of
having a tobacco use status identification
system in place on rates of clinician
intervention with their patients who smoke (n…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-fullreport.pdf
February 14, 2018 - Developments in pediatric psychopharmacology: Focus on
stimulants, antidepressants, and antipsychotics
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Developments in pediatric psychopharmacology: Focus on
stimulants, antidepressants, and antipsychotics
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Developments in pediatric psychopharmacology: Focus on
stimulants, antidepressants, and antipsychotics